providing pharmaceutical industries with the highest quality of Reference Materials (RMs) such as Active Pharmaceutical Ingredient (API) Reference Standards and Related Substances Reference Standards while offering economical advantages.
From the development to customer delivery, all processes are performed with proficiency and high levels of scientific knowledge including patent information to acquire non-infringe or novel synthetic schemes and compounds. Analytical methods are validated to ensure quality, accuracy and repeatability. To provide traceability information for satisfaction of regulatory requirements, full documentation of all work performed is available.
Furthermore, to give the most benefit to patients and practitioners, we are planning to expand our expertise to discover new candidate drugs including New Chemical Entities (NCEs) and New Derivatives with the highest quality.